{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T04:27:35Z","timestamp":1785472055018,"version":"3.56.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:00:00Z","timestamp":1736467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:00:00Z","timestamp":1736467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Institute of Health, United States","award":["R43 DK120175"],"award-info":[{"award-number":["R43 DK120175"]}]},{"name":"National Institute of Health, United States","award":["R01 HL076179"],"award-info":[{"award-number":["R01 HL076179"]}]},{"name":"National Institute of Health, United States","award":["R01 HL076179"],"award-info":[{"award-number":["R01 HL076179"]}]},{"name":"National Institute of Health, United States","award":["R43 DK120175"],"award-info":[{"award-number":["R43 DK120175"]}]},{"name":"National Institute of Health, United States","award":["R01 HL076179"],"award-info":[{"award-number":["R01 HL076179"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Chronic kidney disease (CKD) is a leading cause of death in the United States, and renal fibrosis represents a pathologic hallmark of CKD. Extracellular cold-inducible RNA-binding protein (eCIRP) is a stress response protein involved in acute inflammation, tissue injury and regulated cell death. However, the role of eCIRP in chronic inflammation and tissue injury has not been elucidated. We hypothesize that eCIRP is involved in renal ischemia\/reperfusion (RIR)-induced CKD and that C23, an antagonist to eCIRP, is beneficial in attenuating renal fibrosis and ferroptosis in RIR-induced CKD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>C57BL\/6 (WT) or CIRP<jats:sup>\u2212\/\u2212<\/jats:sup> mice underwent renal injury with total blockage of blood perfusion by clamping bilateral renal pedicles for 28\u00a0min. In the WT mice at the time of reperfusion, they were treated with C23 (8\u00a0mg\/kg) or vehicle. Blood and kidneys were harvested for further analysis at 21 days thereafter. In a separate cohort, mice underwent bilateral RIR and treatment with C23 or vehicle and were then subjected to left nephrectomy 72\u00a0h thereafter. Mice were then monitored for additional 19 days, and glomerular filtration rate (GFR) was assessed using a noninvasive transcutaneous method.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In the RIR-induced CKD, CIRP<jats:sup>\u2212\/\u2212<\/jats:sup> mice showed decreased collagen deposition, fibronectin staining, and renal injury as compared to the WT mice. Administration of C23 ameliorated renal fibrosis by decreasing the expression of active TGF-\u03b21, \u03b1-SMA, collagen deposition, fibronectin and macrophage infiltration to the kidneys. Furthermore, intervention with C23 significantly decreased renal ferroptosis by reducing iron accumulation, increasing the expression of glutathione peroxidase 4 (GPX4) and lipid peroxidation in the kidneys of RIR-induced CKD mice. Treatment with C23 also attenuated BUN and creatinine. Finally, GFR was significantly decreased in RIR mice with left nephrectomy and C23 treatment partially prevented their decrease.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our data show that eCIRP plays an important role in RIR-induced CKD. Treatment with C23 decreased renal inflammation, alleviated chronic renal injury and fibrosis, and inhibited ferroptosis in the RIR-induced CKD mice.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s10020-025-01071-2","type":"journal-article","created":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T16:58:26Z","timestamp":1736528306000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["An eCIRP inhibitor attenuates fibrosis and ferroptosis in ischemia and reperfusion induced chronic kidney disease"],"prefix":"10.1186","volume":"31","author":[{"given":"Fangming","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijian","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asha","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,10]]},"reference":[{"key":"1071_CR58","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nrneph.2014.68","volume":"10","author":"HJ Anders","year":"2014","unstructured":"Anders HJ. Immune system modulation of kidney regeneration\u2013mechanisms and implications. Nat Rev Nephrol. 2014;10:347\u201358.","journal-title":"Nat Rev Nephrol"},{"key":"1071_CR48","doi-asserted-by":"crossref","unstructured":"Andre C, Bodeau S, Kamel S, Bennis Y, Caillard P. The AKI-to-CKD transition: the role of Uremic Toxins. Int J Mol Sci 2023; 24.","DOI":"10.3390\/ijms242216152"},{"key":"1071_CR22","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/JLB.3MIR1118-443R","volume":"106","author":"M Aziz","year":"2019","unstructured":"Aziz M, Brenner M, Wang P. Extracellular CIRP (eCIRP) and inflammation. J Leukoc Biol. 2019;106:133\u201346.","journal-title":"J Leukoc Biol"},{"key":"1071_CR3","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","volume":"383","author":"GL Bakris","year":"2020","unstructured":"Bakris GL, Agarwal R, Anker SD, Pitt B, Ruilope LM, Rossing P, Kolkhof P, Nowack C, Schloemer P, Joseph A, Filippatos G, Investigators F-D. Effect of Finerenone on chronic kidney Disease outcomes in type 2 diabetes. N Engl J Med. 2020;383:2219\u201329.","journal-title":"N Engl J Med"},{"key":"1071_CR25","doi-asserted-by":"publisher","first-page":"721970","DOI":"10.3389\/fimmu.2021.721970","volume":"12","author":"S Bolourani","year":"2021","unstructured":"Bolourani S, Sari E, Brenner M, Wang P. Extracellular CIRP induces an inflammatory phenotype in pulmonary fibroblasts via TLR4. Front Immunol. 2021;12:721970.","journal-title":"Front Immunol"},{"key":"1071_CR34","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1097\/01.ASN.0000033611.79556.AE","volume":"13","author":"EP Bottinger","year":"2002","unstructured":"Bottinger EP, Bitzer M. TGF-beta signaling in renal disease. J Am Soc Nephrol. 2002;13:2600\u201310.","journal-title":"J Am Soc Nephrol"},{"key":"1071_CR10","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/nrd.2016.67","volume":"15","author":"MD Breyer","year":"2016","unstructured":"Breyer MD, Susztak K. The next generation of therapeutics for chronic kidney disease. Nat Rev Drug Discov. 2016;15:568\u201388.","journal-title":"Nat Rev Drug Discov"},{"key":"1071_CR40","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00441-011-1227-1","volume":"347","author":"RM Carew","year":"2012","unstructured":"Carew RM, Wang B, Kantharidis P. The role of EMT in renal fibrosis. Cell Tissue Res. 2012;347:103\u201316.","journal-title":"Cell Tissue Res"},{"key":"1071_CR28","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.surg.2016.04.014","volume":"160","author":"C Cen","year":"2016","unstructured":"Cen C, Yang WL, Yen HT, Nicastro JM, Coppa GF, Wang P. Deficiency of cold-inducible ribonucleic acid-binding protein reduces renal injury after ischemia-reperfusion. Surgery. 2016;160:473\u201383.","journal-title":"Surgery"},{"key":"1071_CR36","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.lfs.2007.06.032","volume":"81","author":"T de Jesus Soares","year":"2007","unstructured":"de Jesus Soares T, Volpini RA, Francescato HD, Costa RS, da Silva CG, Coimbra TM. Effects of resveratrol on glycerol-induced renal injury. Life Sci. 2007;81:647\u201356.","journal-title":"Life Sci"},{"key":"1071_CR26","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1016\/j.jpedsurg.2018.12.020","volume":"54","author":"NL Denning","year":"2019","unstructured":"Denning NL, Yang WL, Hansen L, Prince J, Wang P. C23, an oligopeptide derived from cold-inducible RNA-binding protein, suppresses inflammation and reduces lung injury in neonatal sepsis. J Pediatr Surg. 2019;54:2053\u201360.","journal-title":"J Pediatr Surg"},{"key":"1071_CR20","doi-asserted-by":"crossref","unstructured":"Denning NL, Aziz M, Murao A, Gurien SD, Ochani M, Prince JM, Wang P. Extracellular CIRP as an endogenous TREM-1 ligand to fuel inflammation in sepsis. JCI Insight 2020; 5.","DOI":"10.1172\/jci.insight.134172"},{"key":"1071_CR16","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS, Morrison B. 3rd, Stockwell BR. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149:1060\u201372.","journal-title":"Cell"},{"key":"1071_CR11","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1172\/JCI72267","volume":"124","author":"JS Duffield","year":"2014","unstructured":"Duffield JS. Cellular and molecular mechanisms in kidney fibrosis. J Clin Invest. 2014;124:2299\u2013306.","journal-title":"J Clin Invest"},{"key":"1071_CR55","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nrneph.2014.246","volume":"11","author":"LL Falke","year":"2015","unstructured":"Falke LL, Gholizadeh S, Goldschmeding R, Kok RJ, Nguyen TQ. Diverse origins of the myofibroblast-implications for kidney fibrosis. Nat Rev Nephrol. 2015;11:233\u201344.","journal-title":"Nat Rev Nephrol"},{"key":"1071_CR59","first-page":"189","volume":"34","author":"H Fattah","year":"2019","unstructured":"Fattah H, Layton A, Vallon V. How do kidneys adapt to a deficit or loss in nephron number? Physiol (Bethesda). 2019;34:189\u201397.","journal-title":"Physiol (Bethesda)"},{"key":"1071_CR44","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/ncb3064","volume":"16","author":"JP Friedmann Angeli","year":"2014","unstructured":"Friedmann Angeli JP, Schneider M, Proneth B, Tyurina YY, Tyurin VA, Hammond VJ, Herbach N, Aichler M, Walch A, Eggenhofer E, Basavarajappa D, R\u00e5dmark O, Kobayashi S, Seibt T, Beck H, Neff F, Esposito I, Wanke R, F\u00f6rster H, Yefremova O, Heinrichmeyer M, Bornkamm GW, Geissler EK, Thomas SB, Stockwell BR, O\u2019Donnell VB, Kagan VE, Schick JA, Conrad M. Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat Cell Biol. 2014;16:1180\u201391.","journal-title":"Nat Cell Biol"},{"key":"1071_CR1","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/nrneph.2016.163","volume":"13","author":"RJ Glassock","year":"2017","unstructured":"Glassock RJ, Warnock DG, Delanaye P. The global burden of chronic kidney disease: estimates, variability and pitfalls. Nat Rev Nephrol. 2017;13:104\u201314.","journal-title":"Nat Rev Nephrol"},{"key":"1071_CR14","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/nm.3901","volume":"21","author":"MT Grande","year":"2015","unstructured":"Grande MT, Sanchez-Laorden B, Lopez-Blau C, De Frutos CA, Boutet A, Arevalo M, Rowe RG, Weiss SJ, Lopez-Novoa JM, Nieto MA. Snail1-induced partial epithelial-to-mesenchymal transition drives renal fibrosis in mice and can be targeted to reverse established disease. Nat Med. 2015;21:989\u201397.","journal-title":"Nat Med"},{"key":"1071_CR18","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41419-023-05969-9","volume":"14","author":"R Guo","year":"2023","unstructured":"Guo R, Duan J, Pan S, Cheng F, Qiao Y, Feng Q, Liu D, Liu Z. The Road from AKI to CKD: Molecular mechanisms and therapeutic targets of Ferroptosis. Cell Death Dis. 2023;14:426.","journal-title":"Cell Death Dis"},{"key":"1071_CR8","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","volume":"383","author":"HJL Heerspink","year":"2020","unstructured":"Heerspink HJL, Stefansson BV, Correa-Rotter R, Chertow GM, Greene T, Hou FF, Mann JFE, McMurray JJV, Lindberg M, Rossing P, Sjostrom CD, Toto RD, Langkilde AM, Wheeler DC. Committees D-CT, investigators. Dapagliflozin in patients with chronic kidney disease. N Engl J Med. 2020;383:1436\u201346.","journal-title":"N Engl J Med"},{"key":"1071_CR29","doi-asserted-by":"publisher","first-page":"F558","DOI":"10.1152\/ajprenal.00004.2023","volume":"324","author":"Z Hu","year":"2023","unstructured":"Hu Z, Zhang F, Brenner M, Jacob A, Wang P. The protective effect of H151, a novel STING inhibitor, in renal ischemia-reperfusion-induced acute kidney injury. Am J Physiol Ren Physiol. 2023;324:F558\u201367.","journal-title":"Am J Physiol Ren Physiol"},{"key":"1071_CR49","doi-asserted-by":"crossref","unstructured":"Ide S, Kobayashi Y, Ide K, Strausser SA, Abe K, Herbek S, O\u2019Brien LL, Crowley SD, Barisoni L, Tata A, Tata PR, Souma T. Ferroptotic stress promotes the accumulation of pro-inflammatory proximal tubular cells in maladaptive renal repair. Elife 2021; 10.","DOI":"10.7554\/eLife.68603"},{"key":"1071_CR31","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/path.4104","volume":"229","author":"F Klingberg","year":"2013","unstructured":"Klingberg F, Hinz B, White ES. The myofibroblast matrix: implications for tissue repair and fibrosis. J Pathol. 2013;229:298\u2013309.","journal-title":"J Pathol"},{"key":"1071_CR54","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/s41586-020-2941-1","volume":"589","author":"C Kuppe","year":"2021","unstructured":"Kuppe C, Ibrahim MM, Kranz J, Zhang X, Ziegler S, Perales-Paton J, Jansen J, Reimer KC, Smith JR, Dobie R, Wilson-Kanamori JR, Halder M, Xu Y, Kabgani N, Kaesler N, Klaus M, Gernhold L, Puelles VG, Huber TB, Boor P, Menzel S, Hoogenboezem RM, Bindels EMJ, Steffens J, Floege J, Schneider RK, Saez-Rodriguez J, Henderson NC, Kramann R. Decoding myofibroblast origins in human kidney fibrosis. Nature. 2021;589:281\u20136.","journal-title":"Nature"},{"key":"1071_CR38","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1038\/nm.3218","volume":"19","author":"VS LeBleu","year":"2013","unstructured":"LeBleu VS, Taduri G, O\u2019Connell J, Teng Y, Cooke VG, Woda C, Sugimoto H, Kalluri R. Origin and function of myofibroblasts in kidney fibrosis. Nat Med. 2013;19:1047\u201353.","journal-title":"Nat Med"},{"key":"1071_CR57","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1681\/ASN.2013020152","volume":"25","author":"M Lech","year":"2014","unstructured":"Lech M, Grobmayr R, Ryu M, Lorenz G, Hartter I, Mulay SR, Susanti HE, Kobayashi KS, Flavell RA, Anders HJ. Macrophage phenotype controls long-term AKI outcomes\u2013kidney regeneration versus atrophy. J Am Soc Nephrol. 2014;25:292\u2013304.","journal-title":"J Am Soc Nephrol"},{"key":"1071_CR53","doi-asserted-by":"crossref","unstructured":"Lever JM, Hull TD, Boddu R, Pepin ME, Black LM, Adedoyin OO, Yang Z, Traylor AM, Jiang Y, Li Z, Peabody JE, Eckenrode HE, Crossman DK, Crowley MR, Bolisetty S, Zimmerman KA, Wende AR, Mrug M, Yoder BK, Agarwal A, George JF. Resident macrophages reprogram toward a developmental state after acute kidney injury. JCI Insight 2019; 4.","DOI":"10.1172\/jci.insight.125503"},{"key":"1071_CR42","doi-asserted-by":"publisher","first-page":"2187236","DOI":"10.1080\/0886022X.2023.2187236","volume":"45","author":"L Li","year":"2023","unstructured":"Li L, Ye H, Chen Q, Wei L. COL28 promotes proliferation, migration, and EMT of renal tubular epithelial cells. Ren Fail. 2023;45:2187236.","journal-title":"Ren Fail"},{"key":"1071_CR39","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.2353\/ajpath.2008.080433","volume":"173","author":"SL Lin","year":"2008","unstructured":"Lin SL, Kisseleva T, Brenner DA, Duffield JS. Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney. Am J Pathol. 2008;173:1617\u201327.","journal-title":"Am J Pathol"},{"key":"1071_CR17","doi-asserted-by":"publisher","first-page":"7686956","DOI":"10.1155\/2022\/7686956","volume":"2022","author":"Y Liu","year":"2022","unstructured":"Liu Y, Wang J. Ferroptosis, a rising force against Renal Fibrosis. Oxid Med Cell Longev. 2022;2022:7686956.","journal-title":"Oxid Med Cell Longev"},{"key":"1071_CR15","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1038\/nm.3902","volume":"21","author":"S Lovisa","year":"2015","unstructured":"Lovisa S, LeBleu VS, Tampe B, Sugimoto H, Vadnagara K, Carstens JL, Wu CC, Hagos Y, Burckhardt BC, Pentcheva-Hoang T, Nischal H, Allison JP, Zeisberg M, Kalluri R. Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis. Nat Med. 2015;21:998\u20131009.","journal-title":"Nat Med"},{"key":"1071_CR27","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/SHK.0000000000000988","volume":"49","author":"J McGinn","year":"2018","unstructured":"McGinn J, Zhang F, Aziz M, Yang WL, Nicastro J, Coppa GF, Wang P. The Protective Effect of a short peptide derived from Cold-Inducible RNA-Binding protein in Renal Ischemia-Reperfusion Injury. Shock. 2018;49:269\u201376.","journal-title":"Shock"},{"key":"1071_CR35","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1042\/CS20120252","volume":"124","author":"XM Meng","year":"2013","unstructured":"Meng XM, Chung AC, Lan HY. Role of the TGF-beta\/BMP-7\/Smad pathways in renal diseases. Clin Sci (Lond). 2013;124:243\u201354.","journal-title":"Clin Sci (Lond)"},{"key":"1071_CR30","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrneph.2016.48","volume":"12","author":"XM Meng","year":"2016","unstructured":"Meng XM, Nikolic-Paterson DJ, Lan HY. TGF-\u03b2: the master regulator of fibrosis. Nat Rev Nephrol. 2016;12:325\u201338.","journal-title":"Nat Rev Nephrol"},{"key":"1071_CR56","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1038\/ki.2011.482","volume":"81","author":"SR Mulay","year":"2012","unstructured":"Mulay SR, Thomasova D, Ryu M, Anders HJ. MDM2 (murine double minute-2) links inflammation and tubular cell healing during acute kidney injury in mice. Kidney Int. 2012;81:1199\u2013211.","journal-title":"Kidney Int"},{"key":"1071_CR4","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1056\/NEJMoa1611925","volume":"377","author":"B Neal","year":"2017","unstructured":"Neal B, Perkovic V, Mahaffey KW, de Zeeuw D, Fulcher G, Erondu N, Shaw W, Law G, Desai M, Matthews DR, Group CPC. Canagliflozin and Cardiovascular and renal events in type 2 diabetes. N Engl J Med. 2017;377:644\u201357.","journal-title":"N Engl J Med"},{"key":"1071_CR2","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1152\/physrev.00027.2022","volume":"103","author":"R Norregaard","year":"2023","unstructured":"Norregaard R, Mutsaers HAM, Frokiaer J, Kwon TH. Obstructive nephropathy and molecular pathophysiology of renal interstitial fibrosis. Physiol Rev. 2023;103:2827\u201372.","journal-title":"Physiol Rev"},{"key":"1071_CR9","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","volume":"383","author":"M Packer","year":"2020","unstructured":"Packer M, Anker SD, Butler J, Filippatos G, Pocock SJ, Carson P, Januzzi J, Verma S, Tsutsui H, Brueckmann M, Jamal W, Kimura K, Schnee J, Zeller C, Cotton D, Bocchi E, Bohm M, Choi DJ, Chopra V, Chuquiure E, Giannetti N, Janssens S, Zhang J, Gonzalez Juanatey JR, Kaul S, Brunner-La Rocca HP, Merkely B, Nicholls SJ, Perrone S, Pina I, Ponikowski P, Sattar N, Senni M, Seronde MF, Spinar J, Squire I, Taddei S, Wanner C, Zannad F. Investigators EM-RT. Cardiovascular and renal outcomes with Empagliflozin in Heart failure. N Engl J Med. 2020;383:1413\u201324.","journal-title":"N Engl J Med"},{"key":"1071_CR5","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","volume":"380","author":"V Perkovic","year":"2019","unstructured":"Perkovic V, Jardine MJ, Neal B, Bompoint S, Heerspink HJL, Charytan DM, Edwards R, Agarwal R, Bakris G, Bull S, Cannon CP, Capuano G, Chu PL, de Zeeuw D, Greene T, Levin A, Pollock C, Wheeler DC, Yavin Y, Zhang H, Zinman B, Meininger G, Brenner BM, Mahaffey KW, Investigators CT. Canagliflozin and renal outcomes in type 2 diabetes and nephropathy. N Engl J Med. 2019;380:2295\u2013306.","journal-title":"N Engl J Med"},{"key":"1071_CR41","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1038\/s41419-018-1157-x","volume":"9","author":"R Qi","year":"2018","unstructured":"Qi R, Yang C. Renal tubular epithelial cells: the neglected mediator of tubulointerstitial fibrosis after injury. Cell Death Dis. 2018;9:1126.","journal-title":"Cell Death Dis"},{"key":"1071_CR19","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1038\/nm.3368","volume":"19","author":"X Qiang","year":"2013","unstructured":"Qiang X, Yang WL, Wu R, Zhou M, Jacob A, Dong W, Kuncewitch M, Ji Y, Yang H, Wang H, Fujita J, Nicastro J, Coppa GF, Tracey KJ, Wang P. Cold-inducible RNA-binding protein (CIRP) triggers inflammatory responses in hemorrhagic shock and sepsis. Nat Med. 2013;19:1489\u201395.","journal-title":"Nat Med"},{"key":"1071_CR52","doi-asserted-by":"publisher","first-page":"F1501","DOI":"10.1152\/ajprenal.00195.2018","volume":"315","author":"Y Sato","year":"2018","unstructured":"Sato Y, Yanagita M. Immune cells and inflammation in AKI to CKD progression. Am J Physiol Ren Physiol. 2018;315:F1501\u201312.","journal-title":"Am J Physiol Ren Physiol"},{"key":"1071_CR37","doi-asserted-by":"publisher","first-page":"569322","DOI":"10.3389\/fphys.2020.569322","volume":"11","author":"L Sheng","year":"2020","unstructured":"Sheng L, Zhuang S. New insights into the role and mechanism of partial epithelial-mesenchymal transition in kidney fibrosis. Front Physiol. 2020;11:569322.","journal-title":"Front Physiol"},{"key":"1071_CR23","doi-asserted-by":"publisher","first-page":"903859","DOI":"10.3389\/fimmu.2022.903859","volume":"13","author":"J Shimizu","year":"2022","unstructured":"Shimizu J, Murao A, Nofi C, Wang P, Aziz M. Extracellular CIRP promotes GPX4-Mediated ferroptosis in Sepsis. Front Immunol. 2022;13:903859.","journal-title":"Front Immunol"},{"key":"1071_CR50","doi-asserted-by":"publisher","first-page":"954815","DOI":"10.3389\/fphys.2022.954815","volume":"13","author":"S Siskind","year":"2022","unstructured":"Siskind S, Zhang F, Brenner M, Wang P. Extracellular CIRP induces acute kidney injury via endothelial TREM-1. Front Physiol. 2022;13:954815.","journal-title":"Front Physiol"},{"key":"1071_CR46","doi-asserted-by":"publisher","first-page":"6203","DOI":"10.1111\/jcmm.16567","volume":"25","author":"M Sui","year":"2021","unstructured":"Sui M, Xu D, Zhao W, Lu H, Chen R, Duan Y, Li Y, Zhu Y, Zhang L, Zeng L. CIRBP promotes ferroptosis by interacting with ELAVL1 and activating ferritinophagy during renal ischaemia-reperfusion injury. J Cell Mol Med. 2021;25:6203\u201316.","journal-title":"J Cell Mol Med"},{"key":"1071_CR51","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41581-019-0110-2","volume":"15","author":"PM Tang","year":"2019","unstructured":"Tang PM, Nikolic-Paterson DJ, Lan HY. Macrophages: versatile players in renal inflammation and fibrosis. Nat Rev Nephrol. 2019;15:144\u201358.","journal-title":"Nat Rev Nephrol"},{"key":"1071_CR12","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nrm809","volume":"3","author":"JJ Tomasek","year":"2002","unstructured":"Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol. 2002;3:349\u201363.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1071_CR6","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1056\/NEJMoa1515920","volume":"375","author":"C Wanner","year":"2016","unstructured":"Wanner C, Inzucchi SE, Lachin JM, Fitchett D, von Eynatten M, Mattheus M, Johansen OE, Woerle HJ, Broedl UC, Zinman B, Investigators E-RO. Empagliflozin and progression of kidney disease in type 2 diabetes. N Engl J Med. 2016;375:323\u201334.","journal-title":"N Engl J Med"},{"key":"1071_CR7","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1056\/NEJMoa1812389","volume":"380","author":"SD Wiviott","year":"2019","unstructured":"Wiviott SD, Raz I, Sabatine MS. Dapagliflozin and Cardiovascular outcomes in type 2 diabetes. Reply. N Engl J Med. 2019;380:1881\u20132.","journal-title":"N Engl J Med"},{"key":"1071_CR13","doi-asserted-by":"crossref","unstructured":"Wu H, Qiu Z, Wang L, Li W. Renal fibrosis: SIRT1 still of Value. Biomedicines 2024; 12.","DOI":"10.3390\/biomedicines12091942"},{"key":"1071_CR33","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/cr.2009.5","volume":"19","author":"J Xu","year":"2009","unstructured":"Xu J, Lamouille S, Derynck R. TGF-beta-induced epithelial to mesenchymal transition. Cell Res. 2009;19:156\u201372.","journal-title":"Cell Res"},{"key":"1071_CR32","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1182\/blood.V87.4.1439.bloodjournal8741439","volume":"87","author":"L Yaswen","year":"1996","unstructured":"Yaswen L, Kulkarni AB, Fredrickson T, Mittleman B, Schiffman R, Payne S, Longenecker G, Mozes E, Karlsson S. Autoimmune manifestations in the transforming growth factor-beta 1 knockout mouse. Blood. 1996;87:1439\u201345.","journal-title":"Blood"},{"key":"1071_CR43","doi-asserted-by":"publisher","first-page":"111521","DOI":"10.1016\/j.cellsig.2024.111521","volume":"125","author":"T Yu","year":"2025","unstructured":"Yu T, Mai Z, Zhang S, Wang S, Yang W, Ruan Z, Li P, Guo F, Zhang Y, Li J, Wang L, Lin C, Zheng L. ACVR1 mediates renal tubular EMT in kidney fibrosis via AKT activation. Cell Signal. 2025;125:111521.","journal-title":"Cell Signal"},{"key":"1071_CR60","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1097\/TA.0000000000001566","volume":"83","author":"F Zhang","year":"2017","unstructured":"Zhang F, Yang WL, Brenner M, Wang P. Attenuation of hemorrhage-associated lung injury by adjuvant treatment with C23, an oligopeptide derived from cold-inducible RNA-binding protein. J Trauma Acute Care Surg. 2017;83:690\u20137.","journal-title":"J Trauma Acute Care Surg"},{"key":"1071_CR24","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1038\/s41598-017-13139-z","volume":"8","author":"F Zhang","year":"2018","unstructured":"Zhang F, Brenner M, Yang WL, Wang P. A cold-inducible RNA-binding protein (CIRP)-derived peptide attenuates inflammation and organ injury in septic mice. Sci Rep. 2018;8:3052.","journal-title":"Sci Rep"},{"key":"1071_CR47","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/s41419-021-04137-1","volume":"12","author":"B Zhang","year":"2021","unstructured":"Zhang B, Chen X, Ru F, Gan Y, Li B, Xia W, Dai G, He Y, Chen Z. Liproxstatin-1 attenuates unilateral ureteral obstruction-induced renal fibrosis by inhibiting renal tubular epithelial cells ferroptosis. Cell Death Dis. 2021;12:843.","journal-title":"Cell Death Dis"},{"key":"1071_CR21","doi-asserted-by":"crossref","unstructured":"Zhou M, Aziz M, Denning NL, Yen HT, Ma G, Wang P. Extracellular CIRP induces macrophage endotoxin tolerance through IL-6R-mediated STAT3 activation. JCI Insight 2020; 5.","DOI":"10.1172\/jci.insight.133715"},{"key":"1071_CR45","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1021\/acscentsci.7b00028","volume":"3","author":"O Zilka","year":"2017","unstructured":"Zilka O, Shah R, Li B, Friedmann Angeli JP, Griesser M, Conrad M, Pratt DA. On the mechanism of Cytoprotection by Ferrostatin-1 and Liproxstatin-1 and the role of lipid peroxidation in ferroptotic cell death. ACS Cent Sci. 2017;3:232\u201343.","journal-title":"ACS Cent Sci"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-025-01071-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-025-01071-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-025-01071-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T18:02:32Z","timestamp":1736532152000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.1186\/s10020-025-01071-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,10]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1071"],"URL":"https:\/\/doi.org\/10.1186\/s10020-025-01071-2","relation":{},"ISSN":["1528-3658"],"issn-type":[{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,10]]},"assertion":[{"value":"22 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were performed based on the NIH Guide and Care of Laboratory Animals and were approved by the Institutional Animal Care and Use Committee of the Feinstein Institutes for Medical Research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and provided consent for publication of this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"PW is the inventor of a patent entitled \u201cPeptides inhibiting cold-inducible RNA binding protein activity\u201d. PW was a co-founder of TheraSource LLC, which had an exclusive option to license the relevant technology. FZ, and MB were part-time employees of TheraSource LLC when the study was conducted. ZH and AJ declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11"}}